 | |
Vanguard Health Care Fund | VGHCXMutual Fund | |
| Vanguard Health Care Fund | |
| Last update 2025-06-16 | 85 Stocks (2 new) |
| Value $38.20 Bil | Turnover 4 % |
Vanguard Health Care Fund Profile
Founded in 1928, Wellington Management Company LLP is among the nation’s oldest and most respected institutional investment managers. The firm has advised Vanguard Health Care Fund since 1984. Fund Manager: Jean M. Hynes, CFA, CEO of Wellington Management Company, Managing Partner and Equity Portfolio Manager.
Vanguard Health Care Fund Investing Philosophy
The Vanguard Health Care Fund seeks long-term capital appreciation by investing in stocks broadly representing the health care industry. The advisor seeks to maintain exposure across five primary subsectors: health services, medical products, specialty pharmaceuticals, major pharmaceuticals and international markets.
Fundamental research focuses on companies with high-quality balance sheets, strong management and the potential for new products that will lead to above-average growth in revenue and earnings. Reflecting the advisor’s contrarian style, stocks may be purchased after negative events have caused a decline in share price.
Fundamental research focuses on companies with high-quality balance sheets, strong management and the potential for new products that will lead to above-average growth in revenue and earnings. Reflecting the advisor’s contrarian style, stocks may be purchased after negative events have caused a decline in share price.
Vanguard Health Care Fund's Portfolio
Vanguard Health Care Fund Current Holdings
| Ticker |
|---|
| Ticker |
IRON |
MTSR |
BMY |
NAMS |
NUVL |
PCVX |
MRUS |
SRPT |
APGE |
RNA |
KYMR |
SGRY |
XSWX:GALD |
GKOS |
DNLI |
PTCT |
EXAS |
TMO |
TSE:4578 |
RVMD |
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
IRON | Disc Medicine Inc | 719,845 | 35,733.1 | New Holding | 0.090 | +0.09% | 2.080 | +3.12% | -14.62% | 1,874.8 | Biotechnology | |
MTSR | Metsera Inc | 338,900 | 9,224.9 | New Holding | 0.020 | +0.02% | 0.320 | +2.13% | 0% | 3,016.1 | Biotechnology | |
BMY | Bristol-Myers Squibb Co | 14,760,649 | 900,252.0 | +3,432.92% | 2.360 | +2.29% | 0.730 | -20.36% | -15.71% | 94,936.5 | Drug Manufacturers | |
NAMS | NewAmsterdam Pharma Co NV | 2,156,406 | 44,141.6 | +68.21% | 0.120 | +0.05% | 1.920 | -18.22% | -28.21% | 2,071.4 | Biotechnology | |
NUVL | Nuvalent Inc | 389,500 | 27,623.3 | +56.43% | 0.070 | +0.03% | 0.540 | +7.03% | +1.09% | 5,682.2 | Biotechnology | |
PCVX | Vaxcyte Inc | 3,866,606 | 146,003.0 | +51.80% | 0.380 | +0.13% | 3.000 | -52.04% | -59.83% | 4,241.7 | Biotechnology | |
MRUS | Merus NV | 2,378,055 | 100,092.3 | +50.45% | 0.260 | +0.09% | 3.190 | +19.64% | +26.47% | 3,960.7 | Biotechnology | |
SRPT | Sarepta Therapeutics Inc | 1,804,832 | 115,184.4 | +38.54% | 0.300 | +0.08% | 1.840 | -76.36% | -85.83% | 1,693.3 | Biotechnology | |
APGE | Apogee Therapeutics Inc | 2,605,583 | 97,344.6 | +30.28% | 0.250 | +0.06% | 4.470 | +9.14% | -3.29% | 2,554.7 | Biotechnology | |
RNA | Avidity Biosciences Inc | 3,030,557 | 89,462.0 | +28.76% | 0.230 | +0.05% | 2.510 | -6.93% | +2.58% | 3,595.1 | Biotechnology | |
KYMR | Kymera Therapeutics Inc | 3,013,587 | 82,481.9 | +28.16% | 0.220 | +0.05% | 4.630 | +50.41% | +13.62% | 2,976.6 | Biotechnology | |
SGRY | Surgery Partners Inc | 4,602,252 | 109,303.5 | +27.49% | 0.290 | +0.06% | 3.590 | -9.66% | +2.50% | 2,781.1 | Healthcare Providers & Services | |
XSWX:GALD | Galderma Group AG | 4,311,231 | 455,623.9 | +20.44% | 1.190 | +0.20% | 1.820 | +23.02% | +14.56% | 27,325.4 | Drug Manufacturers | |
GKOS | Glaukos Corp | 1,022,684 | 100,652.6 | +20.44% | 0.260 | +0.04% | 1.790 | -2.01% | -32.60% | 5,774.6 | Medical Devices & Instruments | |
DNLI | Denali Therapeutics Inc | 9,560,542 | 129,975.6 | +19.93% | 0.340 | +0.06% | 6.580 | +4.92% | -28.90% | 2,105.1 | Biotechnology | |
PTCT | PTC Therapeutics Inc | 3,300,514 | 168,194.2 | +18.02% | 0.440 | +0.07% | 4.160 | -10.41% | +9.77% | 3,927.2 | Biotechnology | |
EXAS | Exact Sciences Corp | 6,061,109 | 262,385.4 | +16.39% | 0.690 | +0.10% | 3.210 | +15.34% | -7.79% | 9,773.3 | Medical Diagnostics & Research | |
TMO | Thermo Fisher Scientific Inc | 964,906 | 480,137.2 | +14.63% | 1.260 | +0.16% | 0.260 | -19.69% | -20.63% | 155,572.8 | Medical Diagnostics & Research | |
TSE:4578 | Otsuka Holdings Co Ltd | 7,116,100 | 370,819.9 | +13.00% | 0.970 | +0.11% | 1.350 | -11.85% | -17.45% | 3,749,262.6 | Drug Manufacturers | |
RVMD | Revolution Medicines Inc | 4,819,942 | 170,433.1 | +12.22% | 0.450 | +0.05% | 2.590 | -0.64% | -14.31% | 6,981.3 | Biotechnology |
Total 86
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers